StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
Huagongshe Open Project:[email protected]KI-Anbindung: llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.7.8
  1. Startseite
  2. /Verbindung

N,N, beta-Trimethyl-10H-phenothia-zin-10-propanamin

(+-)-Trimeprazine

HCID 5574
NotizenReaktionen
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
84-96-8
Standard-SMILES
CC(CN(C)C)CN1c2ccccc2Sc2ccccc21
InChIKey
ZZHLYYDVIOPZBE-UHFFFAOYSA-N
Summenformel
C18H22N2S
Durchschnittliche Molmasse
298,4 g/mol
Monoisotopische Masse
298,15036988

Überblick

Trimeprazine is a member of phenothiazines.

Namen und Bezeichner

Bevorzugter Name
(+-)-Trimeprazine
IUPAC
N,N,2-trimethyl-3-phenothiazin-10-ylpropan-1-amine
Lokaler Name
N,N, beta-Trimethyl-10H-phenothia-zin-10-propanamin
Englischer Name
Trimeprazine
Summenformel
C18H22N2S
Molmasse
298.45

Namen und Synonyme

trimeprazineAlimemazine84-96-8Alimezinedl-TrimeprazineRepetinTeralenAlimemazinaBayer 1219(+-)-TrimeprazineAlimemazinum10-(3-(Dimethylamino)-2-methylpropyl)phenothiazine
Weitere Namen anzeigen
TeraleneALIMENAZINETrimeperazineMethylpromazine
RP 6549BAYER-121910-(2-Methyl-3-dimethylaminopropyl)-phenothiazineN,N,beta-Trimethyl-10H-phenothiazine-10-propanamine76H78MJJ52RP-654910H-Phenothiazine-10-propanamine, N,N,beta-trimethyl-Phenothiazine, 10-(3-(dimethylamino)-2-methylpropyl)-

Datenbank-Bezeichner

CAS
84-96-8
PubChem CID
5574
DTXSID
DTXSID9023708
ChEMBL
CHEMBL829
ChEBI
CHEBI:9725
UNII
76H78MJJ52
EC Number
201-577-3
Nikkaji
J4.905K

Eigenschaften

Berechnete Struktureigenschaften

XLogP
4,7
Polarare Oberfläche (TPSA)
31,8 Ų
H-Brücken-Donoren
0
H-Brücken-Akzeptoren
3
Frei drehbare Bindungen
4
Schwere Atome
21
Formalladung
0
Komplexität
311

Experimentelle und physikochemische Eigenschaften

LogP · 2 Einträge

4.6

4.71

Color/FormCRYSTALS
Solubility · 3 Einträge

CRYSTALS; SOL IN WATER; SLIGHTLY SOL IN ALCOHOL /TARTRATE/

WHITE TO OFF-WHITE CRYSTALLINE POWDER; FREELY SOL IN CHLOROFORM; VERY SLIGHTLY SOL IN ETHER & BENZENE /TARTRATE/

8.35e-03 g/L

Human DrugsPharmaceuticals
Boiling Point · 2 Einträge

150-175 °C at 3.00E-01 mm Hg

150-175 °C @ 0.3 MM HG

Melting Point · 2 Einträge

68 °C

68 °C

Physical DescriptionSolid
Stability/Shelf LifeDARKENS ON EXPOSURE TO LIGHT /TARTRATE/
Dissociation Constants · 3 Einträge

9.11

8.5

9.05

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 4 Einträge

Danger

H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P264, P264+P265, P270, P272, P273, P280, P301+P316, P301+P317, P302+P352, P305+P354+P338, P317, P321, P330, P333+P317, P362+P364, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 2 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory InformationREACH registered substance: Alimemazine (EC: 201-577-3)
Hazard Classes and CategoriesAcute Tox. 4 (100%)

Toxikologische Informationen

Interactions · 3 Einträge

...MARKEDLY ENHANCES RESPIRATORY DEPRESSION PRODUCED BY MEPERIDINE. ENHANCEMENT OF EFFECTS OF VARIETY OF DRUGS, PARTICULARLY CNS DEPRESSANTS, IS NOT DUE TO INHIBITION OF HEPATIC MICROSOMAL ENZYMES. IN FACT, PHENOTHIAZINES PROMOTE INDUCTION OF THESE ENZYMES. /PHENOTHIAZINES/

MAY INCR TOXICITY OF ORGANOPHOSPHORUS OR OTHER ACETYLCHOLINESTERASE INHIBITORS & PROCAINE. DO NOT USE EPINEPHRINE TO COMBAT ITS HYPOTENSIVE OR DEPRESSANT EFFECTS AS IT POTENTIATES THEM.

POSSIBILITY OF SEVERE HYPOTHERMIA...IN PATIENTS RECEIVING /CONCOMITANT/ ANTIPYRETIC THERAPY...ADDITIVE WITH, OR MAY POTENTIATE, ACTION OF CNS DEPRESSANTS...ATROPINE, HYPOTENSIVE AGENTS, NARCOTICS, BARBITURATES...OTHER SEDATIVES, ANESTHETICS, TRANQUILIZERS...ALCOHOL. /TARTRATE/

Human Toxicity Excerpts · 5 Einträge

LEUKOCYTOSIS, LEUKOPENIA, & EOSINOPHILIA OCCUR WITH PHENOTHIAZINE MEDICATION. ...HYPERSENSITIVITY REACTION THAT MAY BE URTICARIAL, MACULOPAPULAR, PETECHIAL, OR EDEMATOUS... /PHENOTHIAZINES/

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 2 Einträge

R - Respiratory system

QR - Respiratory system

Pharmacodynamics · 1 Eintrag

Trimeprazine (also known as Alimemazine) is a tricyclic antihistamine, similar in structure to the phenothiazine antipsychotics, but differing in the ring-substitution and chain characteristics. Trimeprazine is in the same class of drugs as chlorpromazine (Thorazine) and trifluoperazine (Stelazine); however, unlike the other drugs in this class, trimeprazine is not used clinically as an anti-psychotic. It acts as an anti-histamine, a sedative, and an anti-emetic (anti-nausea). Trimeprazine is used principally as an anti-emetic, to prevent motion sickness or as an anti-histamine in combination with other medications in cough and cold preparations. Tricyclic antihistamines are also structurally-related to the tricyclic antidepressants, explaining the antihistaminergic adverse effects of these two drug classes and also the poor tolerability profile of tricyclic H<sub>1</sub>-antihistamines.

Mechanism of ActionTrimeprazine competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding.
Metabolism/Metabolites · 3 Einträge

Hepatic

YIELDS 10-(3-DIMETHYLAMINO-2-METHYLPROPYL)PHENOTHIAZINE SULFOXIDE AND 10-(3-METHYLAMINO-2-METHYLPROPYL)PHENOTHIAZINE IN RAT; HEWICK, DS, & BECKETT, AH, BIOCHEM J, 122, 56P (1971). /FROM TABLE/

METABOLIZED PRIMARILY BY THE LIVER. HEPATIC METABOLIC REACTIONS INCLUDE OXIDATION, HYDROXYLATION, DEMETHYLATION, SULFOXIDE FORMATION AND CONJUGATION WITH GLUCURONIC ACID, METABOLIC ALTERATIONS IN THE SIDE CHAIN MAY ALSO OCCUR /HUMAN, ORAL/. /TARTRATE/

MeSH Pharmacological ClassificationAgents, usually topical, that relieve itching (pruritus).
Absorption, Distribution and Excretion · 2 Einträge

Well absorbed in the digestive tract.

ULTIMATE SOJOURN OF PHENOTHIAZINE DRUGS IN BODY IS EXCEEDINGLY LONG. SIX MO AFTER DISCONTINUATION OF THESE DRUGS, VARIOUS METABOLITES ARE DETECTABLE IN URINE. /PHENOTHIAZINES/

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen

Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.

Notizen zur Verbindung

Wird geladen…

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
Collision Cross Section · 2 Einträge

166.8 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

166.59 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Schmelzpunkt
68 °C · 68°C
Siedepunkt
0.3 · bp0.3 150-175°
Dichte
1.1163 · 1.1163 (rough estimate)
Brechungsindex
1.6 · 1.6000 (estimate)
pka
9 · pKa 9.00 (Uncertain)
Wasserlöslichkeit
0.942 mg/L · 0.942 mg/L
CAS Datenbank
84 · 84-96-8
NIST chemische Informationen
Trimeprazine(84-96-8)

...HYPOTHERMIA CAN OCCUR & MAY BE DUE BOTH TO ACTION ON HEAT-REGULATING CENTER & TO DIRECT PERIPHERAL VASODILATATION. SENSITIVITY & ADAPTATION TO ENVIRONMENTAL TEMP CHANGE ARE IMPAIRED SO THAT FATAL HYPERTHERMIA & HEAT STROKE ARE POSSIBLE COMPLICATIONS. /PHENOTHIAZINES/

PT ON THERAPY LASTING OVER ONE MONTH SHOULD BE MONITORED FOR POSSIBLE AGRANULOCYTOSIS, HYPOTENSION, OR PARKINSON-LIKE SYMPTOMS. /TARTRATE/

HYPERSENSITIVITY REACTIONS...CHOLESTATIC JAUNDICE, BLOOD DYSCRASIAS, DERMATOSES...PHOTOSENSITIVITY, GENERALLY OCCUR WITHIN 1ST FEW MO... OCCASIONALLY...AFTER DRUG...DISCONTINUED. CHOLESTATIC JAUNDICE...WITHIN 2 TO 4 WK...IN APPROX 0.1 TO 4% OF...PATIENTS...FATALITIES...RARE /ADVERSE EFFECT/. /TARTRATE/

For more Human Toxicity Excerpts (Complete) data for TRIMEPRAZINE (12 total), please visit the HSDB record page.

Drug Induced Liver Injury · 5 Einträge

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

Alimemazine

DILI Positive

Oral

DOI:10.1016/j.drudis.2019.09.022

Antidote and Emergency Treatment · 2 Einträge

IF PHOTOSENSITIVITY DEVELOPS, PATIENT SHOULD STAY OUT OF THE SUN OR WEAR PROTECTIVE CLOTHING TO PREVENT SOLAR ERYTHEMA...SEVERE HYPOTENSIVE EFFECTS...ALLEVIATED BY...LEVARTERENOL...OR PHENYLEPHRINE. /TARTRATE/

SEVERE HYPOTENSION /FROM OVERDOSAGE/ ALLEVIATED BY...IV LEVARTERENOL...OR PHENYLEPHRINE INFUSIONS...EPHEDRINE, AMPHETAMINES OR CAFFEINE & SODIUM BENZOATE MAY BE USED /AS STIMULANTS/. HYPOTHERMIA...DIFFICULT TO CONTROL... EXCHANGE TRANSFUSIONS MAY BE USEFUL...HEMODIALYSIS...OF LITTLE VALUE. /TARTRATE/

Sicherheitsdaten

Giftige Stoffe Daten
84-96-8(Hazardous Substances Data)
Cellular LocationsMembrane
Metabolite PathwaysAlimemazine H1-Antihistamine Action

Verwendung und Herstellung

Uses · 2 Einträge

MEDICATION (VET):

MEDICATION

Methods of Manufacturing · 2 Einträge

JACOB, ROBERT, US PATENT 2,837,518 (1958 TO RHONE-POULENC).

XYLENE SOLN OF PHENOTHIAZINE IS REFLUXED WITH SODAMIDE...AFTER WHICH SOLN OF (3-CHLORO-2-METHYLPROPYL)DIMETHYLAMINE IN XYLENE...& REFLUXING CONTINUED... TRIMEPRAZINE...EXTRACTED WITH AQ ACID &...LIBERATED WITH ALKALI & EXTRACTED WITH ETHER. ...BASE IS DISTILLED...& REACTED WITH...TARTARIC ACID. ... /TARTRATE/

Formulations/Preparations · 2 Einträge

PANECTYL, VANECTYL, REPELTIN, TEMARIL, THERALENE, VALLERJAN /TARTRATE/

CAPSULES (TIMED-RELEASE) 5 MG, SYRUP 2.5 MG/5 ML, TABLETS 2.5 MG /TARTRATE/

Use ClassificationPharmaceuticals
General Manufacturing InformationIN US IT IS NOT PERMITTED FOR USE IN FOOD PRODUCING ANIMALS.

Anwendungen

VerwendenTrimeprazine is used for treating itching during dermatitis of both allergic and nonallergic origin.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

NatriumamidPhenothiazin1-CHLORO-2-METHYL-3-DIMETHYLAMINOPROPANE

Anbieter30 Anbieter

烟台盛凯伦生物制品有限公司13356901049 · [email protected]
宝鸡缔都医药化工有限公司029-81145305 17791533577 · [email protected]
深圳振强药物研发有限公司0755-66853366 13670046396 · [email protected]
上海陶素生化科技有限公司021-33632979 · [email protected]
上海倍卓生物科技有限公司021-61119791,13386096464 · [email protected]
上海湄水化工科技有限公司021-60549325 18616193163
Qingdao Dexin Chemical Co., Ltd+86-15553333686 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
上海寰川实业有限公司021-61478794 · [email protected]
陕西缔都医药化工有限公司+86-29-87569262 +86-15003564040 · [email protected]
池州凯隆进出口贸易有限公司[email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
南通全益生物科技有限公司0513-66337626 18051384581 · [email protected]
BOC Sciences16314854226 · [email protected]
成都大道三灵生物科技有限公司18108108965 18108108965 · [email protected]
上海陶术生物科技股份有限公司13564774135 · [email protected]
成都标样生物科技有限公司028-81700200 13308200041 · [email protected]
河北贞佳新材料有限公司0319-5925599 13315915972 · [email protected]
烟台盛凯伦化学科技有限公司13356901049 · [email protected]
厦门盈融达化工有限公司+86-0592-6210733 · [email protected]
ATK CHEMICAL COMPANY LIMITED+undefined-21-51877795 · [email protected]
深圳聚合生化科技有限公司+86-400-002-6226 13028896684 · [email protected]
Hefei Hirisun Pharmatech Co., Ltd+8615056975894 · [email protected]
XIAMEN AMITY INDUSTRY AND TRADE CO., LTD.+8618950047208 · [email protected]
TargetMol中国(陶术生物)4008200310 15002144251 · [email protected]
上海莫奇生物科技有限公司13341702378 · [email protected]
重庆卡兰医药有限公司[email protected]
DAYANG CHEM (HANGZHOU) CO.,LTD+86-88938639 +86-17705817739 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354 · [email protected]
Hebei Chuanghai Biotechnology Co., Ltd+86-15350571055 · [email protected]